Related Experiment Video
Updated: Apr 16, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Association between GSTM1 polymorphisms and lung cancer: an updated meta-analysis
Glutathione S-transferase M1 (GSTM1) genetic variations do not appear to increase lung cancer risk. A comprehensive meta-analysis of 38 studies found no significant association between GSTM1 polymorphisms and overall lung cancer susceptibility.
Area of Science:
- Genetics
- Oncology
- Environmental Health
Background:
- Glutathione S-transferase M1 (GSTM1) genetic polymorphisms are investigated for their role in lung cancer susceptibility.
- Previous studies on the association between GSTM1 polymorphisms and lung cancer risk have yielded inconsistent results.
Purpose of the Study:
- To clarify the association between GSTM1 genetic polymorphisms and lung cancer risk through a comprehensive meta-analysis.
Main Methods:
- A meta-analysis was conducted using Revman 5.0 software.
- Literature retrieval, article selection, data collection, and statistical analysis were performed.
- A random-effect model was used to pool odds ratios (ORs) and 95% confidence intervals (CIs) from 38 eligible studies.
Main Results:
- The overall meta-analysis included 5737 lung cancer patients and 6843 cancer-free controls.
- No significant association was found between GSTM1 genetic polymorphisms and lung cancer risk (OR = 1.15, 95%CI = 0.98-1.36, P = 0.08).
- Analysis restricted to Chinese individuals also showed no association (OR = 1.13, 95%CI = 0.97-1.32, P = 0.13).
Conclusions:
- GSTM1 genetic polymorphisms are not associated with an increased risk of developing lung cancer.
- The findings suggest that GSTM1 genotype is not a significant risk factor for lung cancer across diverse populations.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023